Royalty Pharma plc (RPRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ADPT, AKRO, AMLX, APLS, ASND, BGNE and others.
RPRX has a market capitalization of $20.92B, compared to an average peer market cap of $5.24B. RPRX is significantly larger than its average peer.
